BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29889283)

  • 21. A technique for inducing B-cell ablation in chickens by in ovo injection of cyclophosphamide.
    Reynolds DL; Maraqa AD
    Avian Dis; 1999; 43(3):367-75. PubMed ID: 10494404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
    Stone H; Mitchell B; Brugh M
    Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV.
    Yang HM; Zhao J; Xue J; Yang YL; Zhang GZ
    Vaccine; 2017 Jan; 35(1):27-32. PubMed ID: 27889255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced serologic response to Newcastle disease virus in broiler chickens exposed to a Chinese field strain of subgroup J avian leukosis virus.
    Cui Z; Sun S; Wang J
    Avian Dis; 2006 Jun; 50(2):191-5. PubMed ID: 16863066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal antibody decay and antibody-mediated immune responses in chicken pullets fed prebiotics and synbiotics.
    Alizadeh M; Munyaka P; Yitbarek A; Echeverry H; Rodriguez-Lecompte JC
    Poult Sci; 2017 Jan; 96(1):58-64. PubMed ID: 27433011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction between Newcastle disease virus and Escherichia coli endotoxin in chickens.
    El Tayeb AB; Hanson RP
    Avian Dis; 2001; 45(2):313-20. PubMed ID: 11417810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response to Newcastle disease virus in chicken lines divergently selected for cutaneous hypersensitivity.
    Ahmed KA; Saxena VK; Ara A; Singh KB; Sundaresan NR; Saxena M; Rasool TJ
    Int J Immunogenet; 2007 Dec; 34(6):445-55. PubMed ID: 18001302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant NDV expressing cytokines or fliC confers a quick immune response against NDV challenge and resistance to maternal antibody.
    Zhang T; Liu Y; Wang H; Zhang X; Zhu S; Xu P; Yin J; Ren G; Liu J; Li D
    Vet Microbiol; 2016 Nov; 196():107-117. PubMed ID: 27939146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of black cumin seed (Nigella sativa L.) on performance and immune system in newly evolved crossbred laying hens.
    Khan SH; Anjum MA; Parveen A; Khawaja T; Ashraf NM
    Vet Q; 2013; 33(1):13-9. PubMed ID: 23594164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the cell-mediated immune response of chickens vaccinated with Newcastle disease virus as determined by the under-agarose leukocyte-migration-inhibition technique.
    Agrawal PK; Reynolds DL
    Avian Dis; 1991; 35(2):360-4. PubMed ID: 1830203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant-attenuated
    Ding K; Shang K; Yu ZH; Yu C; Jia YY; He L; Liao CS; Li J; Zhang CJ; Li YJ; Wu TC; Cheng XC
    J Vet Sci; 2018 Mar; 19(2):232-241. PubMed ID: 29032660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a virosome vaccine for Newcastle disease virus.
    Kapczynski DR; Tumpey TM
    Avian Dis; 2003; 47(3):578-87. PubMed ID: 14562884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and humoral response of in ovo-bursectomized chickens to experimental challenge with velogenic Newcastle disease virus.
    Marino OC; Hanson RP
    Avian Dis; 1987; 31(2):293-301. PubMed ID: 3619822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of chickens against challenge with the variant virus responsible for Newcastle disease in 1984 by conventional vaccination.
    Alexander DJ; Parsons G
    Vet Rec; 1986 Feb; 118(7):176-7. PubMed ID: 3962129
    [No Abstract]   [Full Text] [Related]  

  • 35. Flow cytometric assessment of chicken T cell-mediated immune responses after Newcastle disease virus vaccination and challenge.
    Dalgaard TS; Norup LR; Pedersen AR; Handberg KJ; Jørgensen PH; Juul-Madsen HR
    Vaccine; 2010 Jun; 28(28):4506-14. PubMed ID: 20434546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective immunity against Newcastle disease: the role of antibodies specific to Newcastle disease virus polypeptides.
    Reynolds DL; Maraqa AD
    Avian Dis; 2000; 44(1):138-44. PubMed ID: 10737654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a novel Newcastle disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein.
    Chumbe A; Izquierdo-Lara R; Calderón K; Fernández-Díaz M; Vakharia VN
    Virol J; 2017 Nov; 14(1):232. PubMed ID: 29169354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of antibodies to Newcastle disease virus in ostriches (Struthio camelus) by an indirect ELISA.
    Williams R; Boshoff CH; Verwoerd D; Schoeman M; van Wyk A; Gerdes TH; Roos K
    Avian Dis; 1997; 41(4):864-9. PubMed ID: 9454920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterium phlei as an oral immunomodulator with Newcastle disease vaccine.
    Sreekumar E; Das SK
    Indian J Exp Biol; 2001 Oct; 39(10):989-92. PubMed ID: 11883522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.